Advertisement

Topics

With its silence on key questions, Omeros raises doubts about its rare disease drug

04:30 EDT 22 Aug 2017 | STAT

The Seattle biotech Omeros has long told investors it has a potential blockbuster for rare diseases, but it won't answer key questions about clinical data.

Original Article: With its silence on key questions, Omeros raises doubts about its rare disease drug

NEXT ARTICLE

More From BioPortfolio on "With its silence on key questions, Omeros raises doubts about its rare disease drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...